‘It really is upwards from here,’ Pacific Edge CEO

‘It really is upwards from here,’ Pacific Edge CEO
Pacific Edge chief executive Peter Meintjes. (Image: Pacific Edge)
Rebecca Howard
Pacific Edge chief executive Peter Meintjes is optimistic that the company can capitalise on its “first-mover advantage” despite its Cxbladder tests losing coverage in the US.Pacific Edge’s suite of Cxbladder tests detects bladder cancer by analysing a urine sample for specific genetic markers. The test is non-invasive, requiring only a small urine sample. The results are combined with clinical data to provide a risk score.The change in disposition toward non-invasive tests that use biomarkers has been “incredibly n...

More Markets

NZ stocks end flat amid Fletcher-SkyCity legal woes
Markets Market Close

NZ stocks end flat amid Fletcher-SkyCity legal woes

Tesla's 14% drop again highlighted the general state of global market uncertainty.

Jamie Gray 06 Jun 2025
SkyCity claims it is entitled to $330m in damages from Fletcher Building
Markets

SkyCity claims it is entitled to $330m in damages from Fletcher Building

The original delivery date of the International Convention Centre was January 2019. 

Rebecca Howard 06 Jun 2025
10 NZ firms could get slice of $200m Fisher KiwiSaver cash
Markets

10 NZ firms could get slice of $200m Fisher KiwiSaver cash

Private equity investing will benefit both KiwiSavers and business, fund manager says.